Cargando…
FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience
BACKGROUND: FOLFIRINOX has been shown to significantly increase both overall survival (OS) and progression-free survival (PFS) in metastatic pancreas cancer. There is limited data regarding the treatment of locally advanced pancreatic cancer. We present a retrospective study of patients with both lo...
Autores principales: | Chllamma, Muralidharan K, Cook, Natalie, Dhani, Neesha C, Giby, Kazim, Dodd, Anna, Wang, Lisa, Hedley, David W, Moore, Malcolm J, Knox, Jennifer J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023770/ https://www.ncbi.nlm.nih.gov/pubmed/27467054 http://dx.doi.org/10.1038/bjc.2016.222 |
Ejemplares similares
-
Lung cancer in never smokers from the Princess Margaret Cancer Centre
por: Korpanty, Grzegorz J., et al.
Publicado: (2018) -
Pivoting the Provision of Smoking Cessation Education in a Virtual Clinical World: The Princess Margaret Cancer Centre Experience
por: Quartey, Naa Kwarley, et al.
Publicado: (2021) -
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial
por: Stockley, Tracy L., et al.
Publicado: (2016) -
Virtual Care during the COVID-19 Pandemic Among Patients with Hematologic Malignancies - a Princess Margaret Cancer Centre Experience
por: Suleman, Adam, et al.
Publicado: (2021) -
1777. Implementation of an Antimicrobial Stewardship Program (ASP) at the Princess Margaret Hospital, Nassau Bahamas
por: Johnson-Thompson, Valencia, et al.
Publicado: (2018)